Nisa Investment Advisors, LLC Biogen Inc. Transaction History

Nisa Investment Advisors, LLC

$24.1 Billion
Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 199,254 shares of BIIB stock, worth $28.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

199,254

Previous 49,793 300.16%

Holding current value

$28.4 Million

Previous $9.65 Million 215.71%

% of portfolio

0.13%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$146.47 - $191.55 $21.9 Million - $28.6 Million	149,461 Added 300.16%	199,254 $30.5 Million
Q3 2024 Oct 24, 2024	SELL	$189.07 - $236.8 $1.27 Million - $1.59 Million	-6,735 Reduced 11.91%	49,793 $9.65 Million
Q2 2024 Jul 19, 2024	BUY	$190.52 - $236.72 $346,746 - $430,830	1,820 Added 3.33%	56,528 $13.1 Million
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $214,776 - $271,190	-1,013 Reduced 1.82%	54,708 $11.8 Million
Q4 2023 Jan 25, 2024	SELL	$222.59 - $267.94 $626,590 - $754,251	-2,815 Reduced 4.81%	55,721 $14.4 Million
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $2.24 Million - $2.53 Million	-8,853 Reduced 13.14%	58,536 $15 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $1.2 Million - $1.38 Million	-4,342 Reduced 6.05%	67,389 $19.2 Million
Q1 2023 May 02, 2023	BUY	$256.56 - $292.34 $969,283 - $1.1 Million	3,778 Added 5.56%	71,731 $19.9 Million
Q4 2022 Feb 02, 2023	SELL	$252.44 - $306.72 $432,177 - $525,104	-1,712 Reduced 2.46%	67,953 $18.8 Million
Q3 2022 Nov 07, 2022	SELL	$194.69 - $268.46 $277,822 - $383,092	-1,427 Reduced 2.01%	69,665 $18.6 Million
Q2 2022 Aug 03, 2022	BUY	$187.54 - $223.02 $505,607 - $601,261	2,696 Added 3.94%	71,092 $14.5 Million
Q1 2022 Apr 29, 2022	SELL	$193.77 - $244.14 $3.26 Million - $4.1 Million	-16,810 Reduced 19.73%	68,396 $14.4 Million
Q4 2021 Feb 03, 2022	BUY	$223.92 - $287.77 $1.56 Million - $2 Million	6,965 Added 8.9%	85,206 $19.3 Million
Q3 2021 Oct 18, 2021	SELL	$282.99 - $369.05 $2.49 Million - $3.25 Million	-8,793 Reduced 10.1%	78,241 $22.1 Million
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $3.98 Million - $6.38 Million	15,380 Added 21.46%	87,034 $30.1 Million
Q1 2021 Apr 26, 2021	SELL	$242.95 - $284.63 $4.27 Million - $5 Million	-17,570 Reduced 19.69%	71,654 $20 Million
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $1.92 Million - $2.89 Million	-8,123 Reduced 8.34%	89,224 $21.8 Million
Q3 2020 Oct 20, 2020	BUY	$264.77 - $305.71 $3.19 Million - $3.69 Million	12,057 Added 14.14%	97,347 $27.6 Million
Q2 2020 Jul 27, 2020	SELL	$258.66 - $342.55 $181,579 - $240,470	-702 Reduced 0.82%	85,290 $22.8 Million
Q1 2020 Apr 17, 2020	BUY	$268.85 - $341.04 $347,354 - $440,623	1,292 Added 1.53%	85,992 $27.2 Million
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $1.32 Million - $1.83 Million	-6,021 Reduced 6.64%	84,700 $25.1 Million
Q3 2019 Oct 17, 2019	BUY	$217.44 - $243.88 $1.73 Million - $1.94 Million	7,963 Added 9.62%	90,721 $21.1 Million
Q2 2019 Jul 12, 2019	SELL	$219.29 - $241.72 $1.57 Million - $1.73 Million	-7,146 Reduced 7.95%	82,758 $19.4 Million
Q1 2019 Apr 17, 2019	SELL	$216.71 - $338.96 $753,283 - $1.18 Million	-3,476 Reduced 3.72%	89,904 $21.3 Million
Q4 2018 Jan 17, 2019	SELL	$278.5 - $352.75 $125,325 - $158,737	-450 Reduced 0.48%	93,380 $28.1 Million
Q3 2018 Oct 16, 2018	BUY	$293.51 - $383.83 $3.36 Million - $4.39 Million	11,443 Added 13.89%	93,830 $33.1 Million
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $1.21 Million - $1.44 Million	-4,706 Reduced 5.4%	82,387 $23.9 Million
Q1 2018 Apr 10, 2018	SELL	$260.13 - $367.91 $481,240 - $680,633	-1,850 Reduced 2.08%	87,093 $24.1 Million
Q4 2017 Jan 12, 2018	BUY	$307.64 - $344.58 $199,966 - $223,977	650 Added 0.74%	88,943 $28.3 Million
Q3 2017 Oct 13, 2017	BUY	$281.15 - $329.69 $24.8 Million - $29.1 Million	88,293	88,293 $27.6 Million

Others Institutions Holding BIIB

# of Institutions

1,010

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Biogen Inc. Transaction History